NEW ZEALAND JUST DAYS FROM LEGALISING MEDICINAL CANNABIS!
(11 December 2018)
Following the third reading of The Misuse of Drugs (Medicinal Cannabis) Amendment Bill and its passing by the House, it’s now just a matter of signing the bill into law by giving it the Royal assent, which is done on the advice of the Prime Minister and the Attorney-General.
Whilst this is tremendous news for many of those patients who will most benefit from medical cannabis, many are disappointed with the bill’s controversial exclusion of intractable pain as a general qualifying condition.
New Zealand’s emerging ‘canna-business’ sector now waits with baited breath for the new regulatory framework (medical cannabis scheme) which looks unlikely to be implemented before 2020.
(30 November 2018)
*** WE ARE SEEKING EXPRESSIONS OF INTEREST FROM NEW ZEALAND’S GREEN FAIRIES FOR HOMEGROWN GENETICS ***
*** ABSOLUTE CONFIDENTIALITY ASSURED ***
Hon Peter Dunne to lead SETEK Cannabis Advisory Board
SETEK Chief Executive Mark Mees has announced two key appointments to the SETEK Advisory Board.
“I am delighted to report that the Hon Peter Dunne has accepted the position of Chairman of SETEK’s Advisory Board, joining experienced M&A specialist, Martin Gray of Armillary Private Capital.”
Hon Peter Dunne said his decision to join SETEK was ultimately an easy one to make.
“The SETEK Board of Directors impressed me not only with their vision and plans to build a successful international business, but also their genuine focus on helping people. Mark demonstrates a balanced mix of corporate thinking and good old-fashioned values that really resonated with me.”
“During my time as Associate Minister of Health I started the process of making cannabis-based medicines more available. But there is more to do” said Hon Dunne.
“With the Misuse of Drugs (Medicinal Cannabis) Amendment Bill making its way through Parliament, I am looking forward to working with the SETEK Board to achieve a mutual vision of making premium quality, New Zealand grown cannabis-based medicinal products available to all those New Zealanders who will benefit from them,” Dunne said.
Mr Mees said that the company is focused on ‘getting it right, not getting there first’.
“We may not be the first cab off the rank to produce Medicinal Cannabis in New Zealand, but our planning and execution will more than compensate. We’re passionately committed to setting the ‘Gold standard’ in this new industry in New Zealand; as a producer; as an employer and as a business partner.
The SETEK name will become synonymous with quality in everything we do.” said Mr Mees.
“Mark has assembled an impressive team and the opportunities ahead are exciting. As Advisory Board members, Martin and myself are looking forward immensely to working with SETEK in every way that we can to help them realise their goals—and I am sure you will see a number of announcements over the coming months,” said Hon Dunne.
Martin Gray added that the company has a number of exciting opportunities in front of it and is well placed to build a significant New Zealand and international business.
SETEK is a 100% New Zealand owned company primed to enter the CBD and Medicinal Cannabis market and expects its first CBD products to be ready for market in 2019. SETEK was co-founded by David Peace and Mark Mees in early 2018.
Media Comment please contact Mark Mees
04 972 59 56 or email@example.com